全文获取类型
收费全文 | 1612篇 |
免费 | 195篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 25篇 |
妇产科学 | 17篇 |
基础医学 | 396篇 |
口腔科学 | 47篇 |
临床医学 | 197篇 |
内科学 | 309篇 |
皮肤病学 | 16篇 |
神经病学 | 199篇 |
特种医学 | 91篇 |
外科学 | 153篇 |
综合类 | 21篇 |
预防医学 | 148篇 |
眼科学 | 19篇 |
药学 | 106篇 |
肿瘤学 | 52篇 |
出版年
2021年 | 20篇 |
2019年 | 19篇 |
2018年 | 22篇 |
2016年 | 17篇 |
2015年 | 23篇 |
2014年 | 34篇 |
2013年 | 41篇 |
2012年 | 60篇 |
2011年 | 78篇 |
2010年 | 52篇 |
2009年 | 32篇 |
2008年 | 67篇 |
2007年 | 105篇 |
2006年 | 58篇 |
2005年 | 56篇 |
2004年 | 68篇 |
2003年 | 51篇 |
2002年 | 38篇 |
2001年 | 47篇 |
2000年 | 41篇 |
1999年 | 44篇 |
1998年 | 28篇 |
1997年 | 39篇 |
1996年 | 28篇 |
1995年 | 27篇 |
1994年 | 19篇 |
1993年 | 34篇 |
1992年 | 32篇 |
1991年 | 28篇 |
1990年 | 38篇 |
1989年 | 41篇 |
1988年 | 38篇 |
1987年 | 32篇 |
1986年 | 40篇 |
1985年 | 36篇 |
1984年 | 23篇 |
1983年 | 22篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 21篇 |
1977年 | 23篇 |
1976年 | 13篇 |
1975年 | 19篇 |
1974年 | 17篇 |
1973年 | 15篇 |
1972年 | 20篇 |
1971年 | 19篇 |
1969年 | 19篇 |
1966年 | 12篇 |
排序方式: 共有1810条查询结果,搜索用时 15 毫秒
11.
The historical development of histochemical methods for monoamines and chemicals involved with cholinergic function is reviewed. The use of these methods to elucidate neurochemical interactions in the substantia nigra and caudate-putamen complex is then discussed. Three hypotheses accounting for the localization of acetylcholinesterase within and/or on substantia nigra, pars compacta neurons are presented and evaluated:
- 1. (a) to catabolize acetylcholine released from afferent cholinergic fibers,
- 2. (b) to catabolize substance P released from some neostriato-nigral axon terminals, and/or
- 3. (c) to serve as a communication link with nigral vasculature.
Keywords: Acetylcholine; Acetylcholinesterase; Substance P; GABA; Enkephalin; 5-Hydroxytryptamine Substantia nigra; Neostriatum; Interactive mechanisms 相似文献
12.
Twenty-six patients underwent surgical repair of a pharyngoesophageal diverticulum at Ochsner Clinic, New Orleans, from 1957 through 1977. The majority of the patients (22) had a one-stage excision with intraluminal packing of the diverticulum and esophageal closure after excision. Of the 22 patients whose diverticula were treated by this method, 16 reported they were asymptomatic postoperatively, and six stated their symptoms improved. There were three complications: two wound infections and a temporary recurrent laryngeal nerve paresis. During long-term follow-up, recurrent diverticula developed in two patients. The addition of packing to the diverticulum and the resection and closure over Maloney's dilator have proven to be important aids in this surgical approach. 相似文献
13.
Janardhan J. Rao Vinaya EC. Kumar Sathavahana V. Chowdary Ram K. Babu Praveen Reddy Jitender Reddy 《Indian journal of otolaryngology and head and neck surgery》2005,57(1):30-34
Determination of obstructive site in obstructive sleep apnoea (OSA) is of paramount importance is planning the management. Cephalometric evaluation of lateral X-rays when combined with clinical assessment and fibreoptic examination of the airway helps in locating the site of obstruction. The usual technique of cephalometry has been modified so as to give a better delineation of the soft tissues. Holding a 2mm card board in the mouth and using barium paste helped in more accurate calculations. Using our technique, various parameters have been quantified and a number of controls were studied and normal range derived. Further improvement in cephalometry has been done by using C.T. cephlometry topogram technique. A topogram is a scan done on a running table top cranio-caudally. Using the topogram technique 38 OSA patients were evaluated for all the parameters. The technique, its advantages over traditional cephalometry and the values obtained in the study are discussed in this paper. 相似文献
14.
S. Carney R. A. Butcher J. K. Dawborn G. Pattison 《Clinical and experimental pharmacology & physiology》1974,1(4):299-308
SUMMARY 1. The biological half-life of minocycline in serum has been studied in twenty-one patients and shown to have no relationship to renal function. There is very little excretion of minocycline by the kidney, and practically none is removed by dialysis.
2. In normal subjects, minocycline therapy is not accompanied by a significant rise in blood urea concentration or urinary urea excretion. However, high doses may produce a marked increase in urea excretion.
3. Of eight patients with impaired renal function who were treated with a normal therapeutic dose of minocycline (200 mg/day), one showed a significant increase in urea excretion and a rise in plasma urea concentration. Two patients with severe unstable renal failure required dialysis following therapy.
4. Minocycline is unlikely to accumulate in patients with renal failure due to its predominantly gastrointestinal excretion and is therefore safe to use. However, its protein catabolic effect is dose dependent and if renal function is impaired, even a small increase in urea production may be sufficient to aggravate uraemia. In such patients the normal therapeutic dose (200 mg/day) should not be exceeded and monitoring of renal function is advisable. 相似文献
2. In normal subjects, minocycline therapy is not accompanied by a significant rise in blood urea concentration or urinary urea excretion. However, high doses may produce a marked increase in urea excretion.
3. Of eight patients with impaired renal function who were treated with a normal therapeutic dose of minocycline (200 mg/day), one showed a significant increase in urea excretion and a rise in plasma urea concentration. Two patients with severe unstable renal failure required dialysis following therapy.
4. Minocycline is unlikely to accumulate in patients with renal failure due to its predominantly gastrointestinal excretion and is therefore safe to use. However, its protein catabolic effect is dose dependent and if renal function is impaired, even a small increase in urea production may be sufficient to aggravate uraemia. In such patients the normal therapeutic dose (200 mg/day) should not be exceeded and monitoring of renal function is advisable. 相似文献
15.
S.P. Steigerwalt N. Brar A. Dhungel D. Butcher S. Steigerwalt M. El-Ghouroury R. Provenzano 《Transplantation proceedings》2009,(10):4184-4187
Introduction
Calcineurin inhibitors (CNI) have brought dramatic improvements in early renal allograft survival. However, CNI are associated with posttransplant hypertension (PTHTN), a risk factor for mortality from cardiovascular disease and graft failure. Sirolimus (SRL) is emerging as an alternative to CNI. SRL effects on blood pressure (BP) in humans are unclear. We compared the prevalence of PTHTN among patients receiving SRL as maintenance immunosuppression with a group receiving CNI by using 24-hour ambulatory BP (AMBP). AMBP has been shown to predict cardiovascular events and progression of kidney disease better than casual office BP measurements in chronic kidney disease (CKD) patients.Methods
Renal transplant recipients with office hypertension (defined as BP > 130/80 or on antihypertensive medications), receiving stable immunosuppression and displaying consistent serum creatinine values for ≥6 months were eligible. We enrolled the first 40 patients to consent. Office BP was measured twice using a BP-Tru machine. AMBP was then analyzed for systolic BP (SBP), diastolic BP (DBP), and nocturnal blood pressure fall (NF; “dipping”). Patients were placed in the SRL group (n = 18) and the CNI group (n = 20) based on their maintenance immunosuppressive protocol. Two patients were excluded because of incomplete data. All patients received mycophenolate mofetil, and 14/38, maintenance steroids. We collected, demographics as well as type and date of renal allograft, medications, comorbidities, CKD stage, proteinuria, and plasma creatinine at the time of study enrollment.Results
Patients in the SRL group displayed lower 24-hour SBP than the CNI group (128.0 ± 10.8 vs 137.7 ± 14; P = .029). Nightime MAP, nightime SBP, and nighttime DBP were all lower in the SRL group. NF did not reach significance between the SRL and CNI groups (44% vs 15%; P = .074). Patient demographics and number of antihypertensive medications did not differ.Conclusion
The lower 24-hour SBP seen in the SRL group by AMBP may lead to improved cardiovascular and renal outcomes over time. Long-term patient follow-up will be needed to clarify the effect of the lower 24-hour SBP. 相似文献16.
M. Pazianas G. P. Butcher J. M. Subhani P. J. Finch L. Ang C. Collins R. P. Heaney M. Zaidi J. D. Maxwell 《Osteoporosis international》2005,16(1):56-63
Calcium malabsorption, hypocalcemia and skeletal demineralization are well-recognized features of untreated celiac disease. This study investigates calcium absorption and bone mineral density (BMD) after a prolonged, over 4 years, treatment with a gluten-free diet. Twenty-four adult females with treated celiac disease and twenty age- and sex-matched control subjects were studied. Mean body mass index (MBI), energy intake, serum calcium, and serum 25(OH)D concentrations in treated celiacs did not differ from controls. However, while both dietary calcium and protein intake were significantly higher in celiacs (P<0.012), fractional calcium absorption was lower (mean percentage±SD; treated 39.8±12 versus controls 52.3±10, P<0.001). Thus, after adjusting for calcium intake, the estimated amount of calcium absorbed daily was similar in both groups. Whole body, spine and trochanter BMD were significantly lower in treated celiac patients compared with controls (P<0.05). There were significant inverse correlations between: serum parathyroid hormone (PTH) and femoral neck or total body BMD (P<0.01), PTH and duration of gluten-free diet (P=0.05), and fractional calcium absorption and alkaline phosphatase (P=0.022). Increased calcium intake could potentially compensate for the reduced fractional calcium absorption in treated adult celiac patients, but may not normalize the BMD. In addition, the inverse correlation between PTH and time following treatment is suggestive of a continuing long-term benefit of gluten withdrawal on bone metabolism in celiac patients. 相似文献
17.
Tymms Kathleen Butcher Belinda E. Sletten Tracey L. Smith Tegan O’Sullivan Catherine Littlejohn Geoffrey Sadler Ricky Tronnberg Rebecca Griffiths Hedley 《Clinical rheumatology》2022,41(4):1105-1114
Clinical Rheumatology - Sleep disturbance and fatigue are commonly reported in ankylosing spondylitis (AS) but specific prevalence and the relationship to disease control are unknown. This... 相似文献
18.
19.
G P Butcher S D Ryder S J Hughes M Stewart N Bird M T Haqqani J M Rhodes 《Digestion》1992,53(3-4):142-148
The use of an ammonia electrode to quantify ammonia liberated by urease from Helicobacter pylori was assessed in an in vitro study. It was found to be highly sensitive (down to 0.7 ppm NH3) and highly reproducible (coefficient of variation 6.0%). Inhibition of urease by bismuth subsalicylate was evaluated as urease testing is often used to assess clearance of H. pylori in patients treated with bismuth. Concentrations of bismuth subsalicylate up to 5 mg/ml had no inhibitory effect but bismuth subsalicylate at 50 mg/ml resulted in 21% inhibition of the urease activity of an ultrasonicated H. pylori suspension. As a preliminary study, the ammonia electrode was assessed in the endoscopy room in comparison with conventional techniques for H. pylori diagnosis. Antral biopsies from 39 patients attending for routine diagnostic endoscopy were subjected to culture, histology, detection of urease activity with a commercially available slide test (CLO) and with the ammonia electrode to detect ammonia liberated from samples placed in urea solution. 21 patients were positive after 1 h with the ammonia electrode, compared to only 17 with the commercially available slide test. 20 were positive on histology and 19 by culture. All samples positive with the ammonia electrode were either positive by culture or by histology. The ammonia electrode offers a quick, sensitive, quantitative and cheap method for the detection and quantification of H. pylori. 相似文献
20.
A non-human primate antiserum was prepared to acute lymphoblastic leukemia of T-cell phenotype (T-ALL) and, after absorptions with normal blood elements, reacted by immunofluorescence and microcytotoxicity to all the T-ALL tested. In addition, the antiserum reacted with cells from about 70% of the common ALL studied and immunoprecipitated the common ALL antigen of 100,000 daltons. However, when the anti-T-ALL serum was absorbed with with lymphoblasts from common ALL, it failed to react with common ALL lymphoblasts, yet reacted significantly with cells from patients with T-ALL phenotype and defined a 100,000-dalton membrane component not found on common ALL lymphoblasts. In addition, sequential immunoprecipitation of 125I-labeled T-ALL membranes by anti- common-ALL serum followed by anti-T-ALL serum detected the T-ALL membrane component of 100,000 daltons that was not found on common ALL. Thus, our results demonstrate the presence of of a unique human T-ALL antigen present on all T-ALL distinct from the common ALL antigen. 相似文献